Analytics
The device uses predictive AI to alert staff about patient's deteriorating conditions.
The acquisition is part of the healthcare tech company's plan to expand globally.
Olive Ventures’ portfolio already contains two companies, Violet and Rotera, that it’s helping get off the ground.
Developed by researchers from an Australian university, the software can also detect a baby's face in a hospital bed.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The proposed system uses brain signals and neural patterns from children.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
The device predicts cardiac arrests using four primary vital signs.
ConcertAI is expanding its collaboration with Janssen to improve study design and increase diversity in clinical trials.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.